These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22678533)

  • 1. [The long-term results of the endovascular treatment of the ischemic heart disease].
    Khaïrutdinov ER; Shugushev ZKh; Maksimkin DA; Faïbushevich AG; Baranovich VIu; Veretnik GI; Tarichko IuV
    Khirurgiia (Mosk); 2012; (3):25-31. PubMed ID: 22678533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of implantation of drug-eluting stents in extensive lesion of the coronary bed according to angiographic and intravascular ultrasound findings].
    Cherkavskaia OV; Savchenko AP; Rudenko BA; Merkulov EV
    Vestn Rentgenol Radiol; 2012; (2):14-9. PubMed ID: 22730754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].
    Kastrati A; Mehilli J; Dirschinger J; Dotzer F; Schuhlen H; Neumann FJ; Fleckenstein M; Pfafferott C; Seyfarth M; Schomig A
    Vestn Rentgenol Radiol; 2012; (2):52-60. PubMed ID: 22730760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term results of chronic occlusion recanalization in patients with coronary heart disease].
    Maslennikov MA; Rudenko BA; Savchenko AP; Karpov IuA
    Vestn Rentgenol Radiol; 2011; (4):13-7. PubMed ID: 22288142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular mechanisms and clinical and morphological risk factors of restenosis].
    Gerasimov AM; Cherkavskaia OV; Maslennikov MA; Kochetov AG
    Vestn Rentgenol Radiol; 2011; (4):58-65. PubMed ID: 22288150
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of in-stent restenosis involving a bifurcation lesion with a dedicated bifurcation device in combination with drug-eluting balloons.
    Grundeken MJ; Boerlage-van Dijk K; Wykrzykowska JJ
    J Invasive Cardiol; 2012 Aug; 24(8):E172-5. PubMed ID: 22865320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficiency of medical versus endovascular treatment using drug-eluting stents in coronary heart disease patients with extensive lesion of the coronary bed].
    Savost'ianov KA; Cherkavskaia OV; Savchenko AP; Rudenko BA
    Vestn Rentgenol Radiol; 2011; (5):11-6. PubMed ID: 22420204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhospital and 12-months results of percutaneous coronary interventions with implantation of Paclitaxel eluting stents in patients with long de novo coronary artery lesions].
    Batyraliev TA; Fettser DV; Sidorenko BA; Preobrazhenskiĭ DV; Niyazova-Karben ZA; Abdramanov KA; Belenkov IuN
    Kardiologiia; 2010; 50(10):17-21. PubMed ID: 21118174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of coronary endovascular revascularisation with sirolimus-eluting stents in patients with ischemic heart disease comorbid with type-2 diabetes mellitus: data from 18-month prospective study].
    Tepliakov AT; Torim IuIu; Kuznetsova AV; Rybal'chenko EV; Krylov AL; Karpov RS
    Ter Arkh; 2009; 81(5):54-60. PubMed ID: 19537588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term prognosis in patients with single-vessel or double-vessel coronary artery disease: does successful revascularization achieved by coronary angioplasty improve late outcome?].
    Kawaharada T
    J Cardiol; 2003 Jul; 42(1):1-11. PubMed ID: 12892036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry.
    Park DW; Kim YH; Song HG; Ahn JM; Oh J; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Jung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    J Am Coll Cardiol; 2011 Jan; 57(2):128-37. PubMed ID: 21211683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
    Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial.
    Martuscelli E; Clementi F; Gallagher MM; D'Eliseo A; Chiricolo G; Nigri A; Marino B; Romeo F;
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):4-8. PubMed ID: 17988889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
    Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
    Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.